CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01260701
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:01.287181+00:00
Published At: 2014-08-04T00:00:00+00:00
Record Updated At: 2016-01-18
Results Posted At: 2014-08-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma of the Gastroesophageal Junction", "Diffuse Gastric Adenocarcinoma", "Gastric Intestinal Type Adenocarcinoma", "Gastric Mixed Adenocarcinoma", "Recurrent Gastric Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-18"
protocolSection.identificationModule.nctId: "NCT01260701"
protocolSection.identificationModule.officialTitle: "A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-08-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.